Skip to content

Clinical trials

Observational Urinary Bladder, Overactive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Observational Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20065
20074
20084
200912
20108
20117
201211
20135
20146
201511
20165
201717
20187
20197
20207
202112
20227
20234
20249
20256
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Unknown status28
Not yet recruiting8
Terminated7
Recruiting6
Withdrawn5
Enrolling by invitation3
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc10
National Taiwan University Hospital10
Allergan6
Pfizer6
Maastricht University Medical Center4
Universiteit Antwerpen4
Astellas Pharma Singapore Pte. Ltd.3
Pierre and Marie Curie University3
Seoul National University Hospital3
The Cleveland Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive167
Urinary Incontinence26
Urinary Incontinence, Urge18
Lower Urinary Tract Symptoms14
Urinary Bladder, Neurogenic11
Multiple Sclerosis7
Urinary Incontinence, Stress7
Pelvic Organ Prolapse6
Urinary Retention6
Urinary Tract Infections6

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.